Correlation Between Ssur Hf and Vivos Therapeutics

Can any of the company-specific risk be diversified away by investing in both Ssur Hf and Vivos Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Ssur Hf and Vivos Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between ssur hf and Vivos Therapeutics, you can compare the effects of market volatilities on Ssur Hf and Vivos Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Ssur Hf with a short position of Vivos Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Ssur Hf and Vivos Therapeutics.

Diversification Opportunities for Ssur Hf and Vivos Therapeutics

0.06

Correlation Coefficient

Ssur Hf  Vivos Therapeutics

Significant diversification

The 3 months correlation between Ssur and Vivos is 0.06. Overlapping area represents the amount of risk that can be diversified away by holding ssur hf and Vivos Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Vivos Therapeutics and Ssur Hf is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on ssur hf are associated (or correlated) with Vivos Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Vivos Therapeutics has no effect on the direction of Ssur Hf i.e., Ssur Hf and Vivos Therapeutics go up and down completely randomly.

Pair Corralation between Ssur Hf and Vivos Therapeutics

Assuming the 90 days horizon Ssur Hf is expected to generate 3.81 times less return on investment than Vivos Therapeutics. But when comparing it to its historical volatility, ssur hf is 1.75 times less risky than Vivos Therapeutics. It trades about 0.07 of its potential returns per unit of risk. Vivos Therapeutics is currently generating about 0.16 of returns per unit of risk over similar time horizon. If you would invest  231.00  in Vivos Therapeutics on May 19, 2025 and sell it today you would earn a total of  180.00  from holding Vivos Therapeutics or generate 77.92% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	96.92%
Values	Daily Returns

ssur hf  vs.  Vivos Therapeutics

ssur hf

Risk-Adjusted Performance

Mild

Compared to the overall equity markets, risk-adjusted returns on investments in ssur hf are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. Despite nearly uncertain technical and fundamental indicators, Ssur Hf reported solid returns over the last few months and may actually be approaching a breakup point.

Vivos Therapeutics

Risk-Adjusted Performance

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Vivos Therapeutics are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively unsteady basic indicators, Vivos Therapeutics unveiled solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Ssur Hf and Vivos Therapeutics

The main advantage of trading using opposite Ssur Hf and Vivos Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Ssur Hf position performs unexpectedly, Vivos Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Vivos Therapeutics will offset losses from the drop in Vivos Therapeutics' long position.

The idea behind ssur hf and Vivos Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.